Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine

Herein, we report the case of a 22-year-old woman with hereditary spherocytosis (HS) whose condition worsened after administration of the coronavirus disease 2019 (COVID-19), mRNA vaccine ‘BNT162b2 Pfizer-BioNTech.’ The woman had been diagnosed with HS in 2005, and her condition remained stable unti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Jun, Seki, Masafumi, Abe, Syori, Kobayashi, Tadahiro, Okitsu, Yoko, Fukuhara, Noriko, Takahashi, Shinichiro, Harigae, Hideo, Kameoka, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012938/
https://www.ncbi.nlm.nih.gov/pubmed/36625832
http://dx.doi.org/10.1080/21645515.2023.2165381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012938/
https://www.ncbi.nlm.nih.gov/pubmed/36625832
http://dx.doi.org/10.1080/21645515.2023.2165381

Ejemplares similares